First Time Loading...

Next Science Ltd
ASX:NXS

Watchlist Manager
Next Science Ltd Logo
Next Science Ltd
ASX:NXS
Watchlist
Price: 0.315 AUD -25% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

NXS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. [ Read More ]

The intrinsic value of one NXS stock under the Base Case scenario is 1.254 AUD. Compared to the current market price of 0.315 AUD, Next Science Ltd is Undervalued by 75%.

Key Points:
NXS Intrinsic Value
Base Case
1.254 AUD
Undervaluation 75%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Next Science Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NXS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Next Science Ltd

Provide an overview of the primary business activities
of Next Science Ltd.

What unique competitive advantages
does Next Science Ltd hold over its rivals?

What risks and challenges
does Next Science Ltd face in the near future?

Summarize the latest earnings call
of Next Science Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Next Science Ltd.

Provide P/S
for Next Science Ltd.

Provide P/E
for Next Science Ltd.

Provide P/OCF
for Next Science Ltd.

Provide P/FCFE
for Next Science Ltd.

Provide P/B
for Next Science Ltd.

Provide EV/S
for Next Science Ltd.

Provide EV/GP
for Next Science Ltd.

Provide EV/EBITDA
for Next Science Ltd.

Provide EV/EBIT
for Next Science Ltd.

Provide EV/OCF
for Next Science Ltd.

Provide EV/FCFF
for Next Science Ltd.

Provide EV/IC
for Next Science Ltd.

Show me price targets
for Next Science Ltd made by professional analysts.

What are the Revenue projections
for Next Science Ltd?

How accurate were the past Revenue estimates
for Next Science Ltd?

What are the Net Income projections
for Next Science Ltd?

How accurate were the past Net Income estimates
for Next Science Ltd?

What are the EPS projections
for Next Science Ltd?

How accurate were the past EPS estimates
for Next Science Ltd?

What are the EBIT projections
for Next Science Ltd?

How accurate were the past EBIT estimates
for Next Science Ltd?

Compare the revenue forecasts
for Next Science Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Next Science Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Next Science Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Next Science Ltd compared to its peers.

Compare the P/E ratios
of Next Science Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Next Science Ltd with its peers.

Analyze the financial leverage
of Next Science Ltd compared to its main competitors.

Show all profitability ratios
for Next Science Ltd.

Provide ROE
for Next Science Ltd.

Provide ROA
for Next Science Ltd.

Provide ROIC
for Next Science Ltd.

Provide ROCE
for Next Science Ltd.

Provide Gross Margin
for Next Science Ltd.

Provide Operating Margin
for Next Science Ltd.

Provide Net Margin
for Next Science Ltd.

Provide FCF Margin
for Next Science Ltd.

Show all solvency ratios
for Next Science Ltd.

Provide D/E Ratio
for Next Science Ltd.

Provide D/A Ratio
for Next Science Ltd.

Provide Interest Coverage Ratio
for Next Science Ltd.

Provide Altman Z-Score Ratio
for Next Science Ltd.

Provide Quick Ratio
for Next Science Ltd.

Provide Current Ratio
for Next Science Ltd.

Provide Cash Ratio
for Next Science Ltd.

What is the historical Revenue growth
over the last 5 years for Next Science Ltd?

What is the historical Net Income growth
over the last 5 years for Next Science Ltd?

What is the current Free Cash Flow
of Next Science Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Next Science Ltd.

Financials

Balance Sheet Decomposition
Next Science Ltd

Current Assets 14m
Cash & Short-Term Investments 9.3m
Receivables 3.6m
Other Current Assets 1.1m
Non-Current Assets 3.9m
PP&E 1.5m
Intangibles 2.4m
Other Non-Current Assets 36.7k
Current Liabilities 3.8m
Accounts Payable 3.2m
Accrued Liabilities 79.7k
Other Current Liabilities 549.7k
Non-Current Liabilities 1.2m
Long-Term Debt 687.2k
Other Non-Current Liabilities 555.6k
Efficiency

Earnings Waterfall
Next Science Ltd

Revenue
22.2m USD
Cost of Revenue
-5.9m USD
Gross Profit
16.2m USD
Operating Expenses
-32.2m USD
Operating Income
-15.9m USD
Other Expenses
-343.6k USD
Net Income
-16.3m USD

Free Cash Flow Analysis
Next Science Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NXS Profitability Score
Profitability Due Diligence

Next Science Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
29/100
Profitability
Score

Next Science Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

NXS Solvency Score
Solvency Due Diligence

Next Science Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
68/100
Solvency
Score

Next Science Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NXS Price Targets Summary
Next Science Ltd

Wall Street analysts forecast NXS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NXS is 0.377 AUD with a low forecast of 0.343 AUD and a high forecast of 0.42 AUD.

Lowest
Price Target
0.343 AUD
9% Upside
Average
Price Target
0.377 AUD
20% Upside
Highest
Price Target
0.42 AUD
33% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

NXS Price
Next Science Ltd

1M 1M
-17%
6M 6M
+31%
1Y 1Y
-56%
3Y 3Y
-81%
5Y 5Y
-81%
10Y 10Y
-77%
Annual Price Range
0.315
52w Low
0.185
52w High
0.72
Price Metrics
Average Annual Return -16.95%
Standard Deviation of Annual Returns 29.96%
Max Drawdown -96%
Shares Statistics
Market Capitalization 91.9m AUD
Shares Outstanding 291 695 008
Percentage of Shares Shorted
N/A

NXS Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Next Science Ltd Logo
Next Science Ltd

Country

Australia

Industry

Health Care

Market Cap

91.9m AUD

Dividend Yield

0%

Description

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2019-04-18. The firm's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms. The firm's product includes XPERIENCE, SURGX, BACTISURE and BLASTX. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SURGX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel. The BLASTX is an antimicrobial wound gel.

Contact

NEW SOUTH WALES
Chatswood
Tower B, The Zenith L 19, 821 Pacific Highway
+61286075124.0
https://www.nextscience.com

IPO

2019-04-18

Employees

-

Officers

MD, CEO & Director
Mr. Harry Thomas Hall
Founder & CTO
Dr. Matthew Franco Myntti
Chief Financial Officer
Marc Zimmerman
Chief Operating Officer
Mr. Jon Swanson
Senior Vice President of North American Sales
Mr. Robert Bell
Company Secretary
Ms. Gillian Maria Nairn AGIA, B.A., BA, L.L.B., L.L.M., LLB, LLM, MAICD

See Also

Discover More
What is the Intrinsic Value of one NXS stock?

The intrinsic value of one NXS stock under the Base Case scenario is 1.254 AUD.

Is NXS stock undervalued or overvalued?

Compared to the current market price of 0.315 AUD, Next Science Ltd is Undervalued by 75%.